Synthetic Biology Market see growth of 19.9% CAGR reaching at USD 8.84 billion by 2022

“The global synthetic biology market is projected to grow at a CAGR of 19.9%. in the next five years”
The synthetic biology market is expected to reach USD 8.84 billion by 2022 from an estimated USD 3.57 billion in 2017, at a CAGR of 19.9%. The key factors driving the growth of this market include the wide range of applications of synthetic biology, rising R&D funding and initiatives, increasing demand for synthetic genes and synthetic cells, and increasing investments in synthetic biology companies. On the other hand, possible environmental and security issues related to synthetic biology are likely to restrain the growth of this market to a certain extent.

Request a Free Sample copy of This Premium Research Report: https://watchersofmarkets.com/collections/marketsandmarkets/products/synthetic-biology-market-by-tool-oligonucleotides-chassis-organisms-enzymes-technology-genome-engineering-ngs-cloning-and-sequencing-application-medical-pharmaceutical-drug-discovery-industrial-renewable-energy-global-forecast-to-2022#tab-questions

“The chassis organisms segment is expected to grow at the highest rate during the forecast period (2017-2022).”
On the basis of tools, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. The chassis organisms segment is expected to witness the highest growth during the forecast period due to the increasing research on chassis organisms and the rising global demand of for alternatives to fossil fuel.

“The gene synthesis technology is expected to hold the largest share of the market in 2017
Based on technology, the synthetic biology market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology. The gene synthesis segment is expected to account for the largest share of the synthetic biology market. This is attributed to the factors such as growth in the energy and agriculture industry; applications in environmental testing; and research in DNA-based vaccines and bioengineered antibodies.

“Pharmaceutical applications are expected to hold the largest share of the synthetic biology market in 2017.”
Based on application, the synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), environmental (bioremediation and biosensing), and food & agriculture applications. The pharmaceuticals subsegment is expected to account for the largest share in the market in 2017. This is attributed to the potential of synthetic biology techniques in the development and manufacturing of APIs and small molecules on a large scale.

“China to witness the highest growth during the forecast period” While the US is expected to hold the largest share of the global synthetic biology market in 2017, China is expected to witness the highest growth during 2017 to 2022. Rising R&D funding and awareness programs regarding synthetic biology are contributing to the growth of synthetic biology market in China.

Read more on this report: https://watchersofmarkets.com/collections/marketsandmarkets/products/synthetic-biology-market-by-tool-oligonucleotides-chassis-organisms-enzymes-technology-genome-engineering-ngs-cloning-and-sequencing-application-medical-pharmaceutical-drug-discovery-industrial-renewable-energy-global-forecast-to-2022
Break of primary participants was as mentioned below:
• By Company Type – Tier 1–28%, Tier 2–33% and Tier 3–39%
• By Designation – C-level–42%, Director Level–33%, Others–25%
• By Region – North America–41%, Europe–35%, Asia Pacific–14%, RoW–10%

The major players in the global synthetic biology market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US). Some other players in this market include Intrexon Corporation (US), Agilent Technologies (US), Amyris (US), Genescript Biotech Corporation (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).

Research Coverage:
The report analyzes the synthetic biology market and aims at estimating the market size and growth potential of this market based on various aspects such as tools, technologies, applications, and regions. The report also includes a competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in-turn would help them, garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by key players in the global synthetic biology market. The report analyzes the global synthetic biology market by tool, technology, application, and region.
• Product and Service Innovation: Detailed insights on upcoming trends and new product and service launches in the global synthetic biology market
• Market Development: Comprehensive information about the lucrative emerging markets by tool, technology, application, and region.
• Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the global synthetic biology market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products in pipeline of leading players in the global market

Related Report:
Global Gene Synthesis Market Analysis 2012-2017 and Forecast 2018-2023
Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base. Unlike DNA replication that occurs in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creation of a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.
The global Gene Synthesis market will reach xxx Million USD in 2017. 99Strategy said Commercial dominates the largest Application share in 2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Gene Synthesis by Gene Length, region and Application, in addition, this report introduces market competition situation among the companies and company profile, besides, market price analysis and value chain features are covered in this report.
Read More: https://watchersofmarkets.com/products/global-gene-synthesis-market-analysis-2012-2017-and-forecast-2018-2023

About Us:
We are a leading market research store (headquartered in The Hague, Netherlands) bringing to you market research insights, analysis and data from many market research publishers around the globe.
Our experienced market research consultants understand a client’s research requirements in precise manner and get as many proposals around the globe as possible on the table suiting your budget and mapping your research goals.
Our only motivation is to provide clients with precise insights into their respective niche markets and offering them the most comprehensive portfolio of business information products.

Contact:
Watchers of Markets
Henriëtte van der Meydreef 144,2492 JG, Den Haag, Netherlands.
Website: https://watchersofmarkets.com/
Phone number: +31- 85 888 111 6
Email Id : [email protected]